T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice

Por Yuan, RuiRong, Casadevall, Arturo, Oh, Jin, Scharff, Matthew D.
Publicado em 1997

Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy

Por Yuan, RuiRong, Kay, Andrea, Berg, William J, Lebwohl, David
Publicado em 2009

Targeted therapy in lymphoma

Por Johnston, Patrick B, Yuan, RuiRong, Cavalli, Franco, Witzig, Thomas E
Publicado em 2010

A Distinct Region in Erythropoietin that Induces Immuno/Inflammatory Modulation and Tissue Protection

Por Yuan, RuiRong, Wang, Bo, Lu, Wei, Maeda, Yasuhiro, Dowling, Peter
Publicado no Neurotherapeutics (2015)

Antibody-mediated Modulation of Cryptococcus neoformans Infection Is Dependent on Distinct Fc Receptor Functions and IgG Subclasses

Por Yuan, RuiRong, Clynes, Raphael, Oh, Jin, Ravetch, Jeffrey V., Scharff, Matthew D.
Publicado em 1998

Erythropoietin: A Potent Inducer of Peripheral Immuno/Inflammatory Modulation in Autoimmune EAE

Por Yuan, RuiRong, Maeda, Yasuhiro, Li, Weiping, Lu, Wei, Cook, Stuart, Dowling, Peter
Publicado em 2008

Isotype Switching Increases Efficacy of Antibody Protection against Cryptococcus neoformans Infection in Mice

Por Yuan, Rui Rong, Spira, Gadi, Oh, Jin, Paizi, Melia, Casadevall, Arturo, Scharff, Matthew D.
Publicado em 1998

Two-dose-level confirmatory study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumors

Por Xu, BingHe, Wu, YiLong, Shen, Lin, Ye, DingWei, Jappe, Annette, Cherfi, Azzeddine, Wang, Hui, Yuan, RuiRong
Publicado em 2011